Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Zelboraf
.
Show all posts
Showing posts with label
Zelboraf
.
Show all posts
Monday, January 14, 2013
Melanomas that develop resistance to vemurafenib also become addicted to the drug
›
Vemurafenib ( marketed as Zelboraf ) is a B-Raf enzyme inhibitor developed by Plexxikon (now part of the Daiichi Sankyo group) and...
Sunday, August 21, 2011
FDA Approves Zelboraf - Potent New Melanoma Drug
›
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced that applications for market approval for vemurafenib ( PLX4032/R...
›
Home
View web version
